After four years of existence, IPDiA has decided to strengthen its growth potential and to move forward even more rapidly on its innovation projects. With its vast experience in key markets, in which integrated silicon passive components have a strong added value, IPDiA has launched a new R&D program, named MediLight 2017, to meet the demands of future innovative medical and lighting markets and the company’s long-term roadmap.
In cooperation with ‘historical’ R&D partners, CEA-Leti and CRISMAT (CNRS, ENSICAEN, UNICAEN), MediLight 2017 will drive IPDiA’s innovation on: high voltage and very high density 3D nanostructured integrated silicon capacitors; 3D Interposer development combining new assembly performances for ultra-miniaturization.
A dedicated pilot line will be installed at IPDiA by CEA-Leti and shared between the partners to support these development projects. It will therefore strengthen IPDiA's innovation centre based in Caen, France. An innovation chain, from fundamental research (CRISMAT), technology innovation (CEA-Leti & IPDiA) to industrialization (IPDiA) will be established.
This initiative will present IPDiA with huge opportunities to set up innovations for advanced medical applications (neuro stimulation for instance), lighting (power LED) and sensors (harsh environment, automotive, etc…).